Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2008-06-24
- Last Posted Date
- 2015-02-19
- Lead Sponsor
- CuraGen Corporation
- Target Recruit Count
- 42
- Registration Number
- NCT00704158
- Locations
- 🇺🇸
Florida Cancer Specialists, Ft. Myers, Florida, United States
🇺🇸Hematology Oncology Associates, Lake Worth, Florida, United States
🇺🇸Georgia Cancer Specialists, Atlanta, Georgia, United States
A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma
- Conditions
- Unresectable Stage III or Stage IV Melanoma
- First Posted Date
- 2006-12-19
- Last Posted Date
- 2015-02-19
- Lead Sponsor
- CuraGen Corporation
- Target Recruit Count
- 117
- Registration Number
- NCT00412828
- Locations
- 🇺🇸
Angeles Clinic and Research Institute, Santa Monica, California, United States
🇺🇸Yale University, New Haven, Connecticut, United States
🇺🇸New York University Medical Center, New York, New York, United States
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
- First Posted Date
- 2006-05-09
- Last Posted Date
- 2016-04-13
- Lead Sponsor
- CuraGen Corporation
- Target Recruit Count
- 390
- Registration Number
- NCT00323518
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸Alta Bates Comprehensive Cancer Center, Berkley, California, United States
🇺🇸Research Facility, La Jolla, California, United States
Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant
- Conditions
- Stomatitis
- First Posted Date
- 2005-02-23
- Last Posted Date
- 2016-03-15
- Lead Sponsor
- CuraGen Corporation
- Registration Number
- NCT00104065
- Locations
- 🇺🇸
Research Facility, Portland, Oregon, United States